HIGH DOSES OF M-TOR INHIBITORS MAY INDUCE PULMONARY PRO-FIBROTIC EFFECTS IN RENAL TRANSPLANT RECIPIENTS: RESULT OF A TRANSLATIONAL COMPARATIVE RESEARCH APPROACH BETWEEN PROGRAF VERSUS EVEROLIMUS